Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
HSBC Upgrades Core Laboratories (CLB) to Overweight
October 19, 2012 1:17 PM EDTHSBC upgraded Core Laboratories (NYSE: CLB) from Neutral to Overweight with a price target of $128.00 (from $129.00).
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on... More
